Diabetic Retinopathy - Pathophysiology to Treatment: A Review

被引:2
|
作者
Singh, Randhir [1 ,2 ]
Walia, Aditya [3 ]
Kaur, Jasleen [3 ]
Kumar, Praveen [4 ]
Verma, Inderjeet [5 ]
Rani, Nidhi [3 ]
机构
[1] Cent Univ Punjab, Dept Pharmacol, Bathinda, Punjab, India
[2] Graph Era Hill Univ, Dept Pharm, Dehra Dun, India
[3] Chitkara Univ, Chitkara Coll Pharm, Chitkara, Punjab, India
[4] SunPharma, PO Barotiwala, Solan 174103, Himachal Prades, India
[5] Maharishi Markandeshwar Deemed Univ, MM Coll Pharm, Ambala, Haryana, India
关键词
Diabetic retinopathy; pathogenesis; microvascular changes; inflammation; diabetes; neurodegeneration; DEXAMETHASONE IMPLANT; OXIDATIVE STRESS; PERICYTE LOSS; IN-VITRO; RANIBIZUMAB; APOPTOSIS; ACTIVATION; RETINA; ANTIOXIDANT; CATARACT;
D O I
10.2174/0115733998259940231105200251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic retinopathy (DR) is a microvascular disease affecting the eyes of diabetic patients, and is the most prevalent complication of diabetes mellitus. Vision improvement is not possible in the majority of DR patients. Several studies have indicated that microvascular changes, inflammation, oxidative stress, and retinal neurodegeneration are involved in the pathogenesis of DR. Therefore, there is an urgent need for the development of new and effective treatment for DR. Understanding the molecular mechanisms involved in the pathogenesis of disease will pave a way for better treatment and management of DR. This article has emphasized the molecular pathogenesis and treatment of DR.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Diabetic retinopathy and diabetic macular edema - Pathophysiology, screening, and novel therapies
    Ciulla, TA
    Amador, AG
    Zinman, B
    DIABETES CARE, 2003, 26 (09) : 2653 - 2664
  • [32] TREATMENT OF DIABETIC RETINOPATHY
    SCOTT, GI
    CULLEN, JF
    BIBLIOTHECA OPHTHALMOLOGICA, 1968, (76): : 146 - &
  • [33] TREATMENT OF DIABETIC RETINOPATHY
    TRAUTMANN, JC
    KEARNS, TP
    POSTGRADUATE MEDICINE, 1969, 45 (06) : 123 - +
  • [34] Role of inflammatory cells in pathophysiology and management of diabetic retinopathy
    Kovoor, Elias
    Chauhan, Sunil K.
    Hajrasouliha, Amir
    SURVEY OF OPHTHALMOLOGY, 2022, 67 (06) : 1563 - 1573
  • [35] TREATMENT OF DIABETIC RETINOPATHY
    CULLEN, JF
    GERIATRICS, 1968, 23 (07) : 137 - &
  • [36] TREATMENT OF DIABETIC RETINOPATHY
    FINE, SL
    RUBIN, ML
    AMERICAN FAMILY PHYSICIAN/GP, 1970, 2 (06) : 64 - &
  • [37] Treatment of diabetic retinopathy
    Ferris, FL
    Davis, MD
    Aiello, LM
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (09): : 667 - 678
  • [38] Infiltrating immune cells and pathophysiology in Diabetic Retinopathy (DR)
    Bhutto, Imran Ahmed
    Vaidya, Tanuja
    Ghosh, Sayan
    Padmanabhan, Archana
    Yazdankhah, Meysam
    Shang, Peng
    Stepicheva, Nadezda A.
    Hose, Stacey L.
    Zigler, J. Samuel, Jr.
    GopiKrishna, Santosh
    Thirumalesh, M. B.
    Lutty, Gerard A.
    Ghosh, Arkasubhra
    Sethu, Swaminathan
    Sinha, Debasish
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [39] The Role of Fractalkine in Diabetic Retinopathy: Pathophysiology and Clinical Implications
    Lee, Cheng-Yung
    Yang, Chang-Hao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (01)
  • [40] The role of protein kinase C in the pathophysiology of diabetic retinopathy
    Lang, GE
    Kampmeier, J
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2002, 219 (11) : 769 - 776